JP Morgan Chase
NBTX

JP Morgan Chase’s Nanobiotix NBTX Stock Holding History

JP Morgan Chase’s Portfolio NBTX Stock Details NBTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$61.3K Buy
+1,706
New +$63.4K ﹤0.01% 6342
2025
Q1 		– Sell
-256
Closed -$735 – 7595
2024
Q4 		$735 Buy
+256
New +$1.02K ﹤0.01% 6764
2023
Q3 		– Sell
-2
Closed -$10 – 7635
2023
Q2 		$10 Buy
+2
New +$9 ﹤0.01% 6817

Other funds holding NBTX

JJ
Johnson & Johnson New Brunswick, New Jersey $799M AUM 253.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
Optiver Holding
Optiver Holding Amsterdam, Netherlands $371B AUM 64.6% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

JP Morgan Chase's NBTX Position: Q2 2026 in Review

JP Morgan Chase opened a new position in Nanobiotix (NBTX) in Q2 2026: 1,706 shares worth $61.3K. The stake represents ﹤0.01% of the portfolio and ranks #6342 among its holdings. This is a return to the name: JP Morgan Chase previously reported a position in NBTX as recently as Q4 2024.

JP Morgan Chase first reported a position in NBTX in Q2 2023 and has held it in 3 quarters since. 19 funds tracked by Wall St. Rank hold NBTX as of Q2 2026.

  • JP Morgan Chase held 1,706 shares of Nanobiotix worth $61.3K as of Q2 2026.
  • Nanobiotix was a new JP Morgan Chase position in Q2 2026.
  • Nanobiotix made up ﹤0.01% of JP Morgan Chase's portfolio in Q2 2026, its #6342 holding.
  • JP Morgan Chase first reported a position in Nanobiotix in Q2 2023 and has held it in 3 quarters since.
  • 19 funds tracked by Wall St. Rank held Nanobiotix as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.